| | |
TyG
|
|---|
| |
Q1 (OR, 95% CI)
|
Q2 (OR, 95% CI)
|
Q3 (OR, 95% CI)
|
Q4 (OR, 95% CI)
|
|---|
|
ALT
|
Q1 (OR, 95% CI)
|
1
|
1.4 (1.0–2.0)
|
2.2 (1.5–3.2)
|
5.0 (3.4–7.2)
|
|
Q2 (OR, 95% CI)
|
1.2 (0.8–1.8)
|
2.3 (1.6–3.3)
|
3.5 (2.5–4.9)
|
7.4 (5.2–10.7)
|
|
Q3 (OR, 95% CI)
|
1.5 (1.0–2.2)
|
2.9 (2.1–4.0)
|
4.6 (3.3–6.4)
|
8.9 (6.3–12.4)
|
|
Q4 (OR, 95% CI)
|
2.2 (1.5–3.4)
|
4.1 (2.9–5.9)
|
7.9 (5.6–11.1)
|
17.3 (12.2–24.4)
|
- Adjusted variables included age, sex, body mass index, systolic blood pressure, uric acid and white blood cell counts
-
NAFLD: nonalcoholic fatty liver disease; AL: alanine aminotransferase; Q1: first quartile; Q2: second quartile; Q3: third quartile; Q4: fourth quartile
